Thomas A Waldmann

9PUBLICATIONS
34CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 04, 2023
Accessory cells precondition naïve T cells and regulatory T cells for cytokine-mediated proliferation.

Noriko Sato, Richard N Bamford, Bonita R Bryant

|Feb 01, 2022
A very long-acting IL-15: implications for the immunotherapy of cancer.

John A Hangasky, Wei Chen, Sigrid P Dubois

|Nov 20, 2021
Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumors.

Kevin Conlon, Dionysios C Watson, Thomas A Waldmann

|Jul 31, 2021
Effective Cytotoxicity of Dendritic Cells against Established T Cell Lymphomas in Mice.

Sigrid Dubois, Thomas A Waldmann, Jürgen R Müller

|Apr 22, 2021
Short-course IL-15 given as a continuous infusion led to a massive expansion of effective NK cells: implications for combination therapy with antitumor antibodies.

Sigrid P Dubois, Milos D Miljkovic, Thomas A Fleisher

|Mar 02, 2021
NF-κB-induced R-loop accumulation and DNA damage select for nucleotide excision repair deficiencies in adult T cell leukemia.

Yunlong He, Nagesh Pasupala, Huijun Zhi

Pageof 2

Frequent Collaborators

2 joint publications

Kevin Conlon

1 joint publications

Joseph Roswarski

1 joint publications

Wei Wei

1 joint publications

Jiejing Yin